BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28745565)

  • 1. Advances in adult acute lymphoblastic leukemia therapy.
    Aldoss I; Stein AS
    Leuk Lymphoma; 2018 May; 59(5):1033-1050. PubMed ID: 28745565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in adult ALL: incorporation of new agents to frontline treatment.
    Leonard J; Stock W
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):28-36. PubMed ID: 29222234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in acute lymphoblastic leukemia in adults.
    Ribera JM
    Curr Opin Oncol; 2011 Nov; 23(6):692-9. PubMed ID: 21892082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsed childhood acute lymphoblastic leukaemia.
    Bhojwani D; Pui CH
    Lancet Oncol; 2013 May; 14(6):e205-17. PubMed ID: 23639321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Young Adults with Acute Lymphoblastic Leukemia.
    Kansagra A; Litzow M
    Curr Hematol Malig Rep; 2017 Jun; 12(3):187-196. PubMed ID: 28353017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia.
    Dinner S; Lee D; Liedtke M
    Leuk Lymphoma; 2014 Aug; 55(8):1715-24. PubMed ID: 24251864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches.
    Locatelli F; Moretta F; Rutella S
    Curr Opin Oncol; 2013 Nov; 25(6):707-15. PubMed ID: 24076579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.
    Ronson A; Tvito A; Rowe JM
    Curr Oncol Rep; 2016 Jun; 18(6):39. PubMed ID: 27207612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
    Jabbour E; Short NJ; Jorgensen JL; Yilmaz M; Ravandi F; Wang SA; Thomas DA; Khoury J; Champlin RE; Khouri I; Kebriaei P; O'Brien SM; Garcia-Manero G; Cortes JE; Sasaki K; Dinardo CD; Kadia TM; Jain N; Konopleva M; Garris R; Kantarjian HM
    Cancer; 2017 Jan; 123(2):294-302. PubMed ID: 27602508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
    Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapeutic strategies in acute lymphoblastic leukemia.
    Jeha S
    Semin Hematol; 2009 Jan; 46(1):76-88. PubMed ID: 19100370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALL.
    Chiaretti S; Jabbour E; Hoelzer D
    Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):301-310. PubMed ID: 29653823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the treatment of adults with acute lymphoblastic leukemia.
    Larson S; Stock W
    Curr Opin Hematol; 2008 Jul; 15(4):400-7. PubMed ID: 18536580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies.
    O'Dwyer KM; Liesveld JL
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):184-192. PubMed ID: 29050691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuing challenges and current issues in acute lymphoblastic leukemia.
    Kansagra A; Dahiya S; Litzow M
    Leuk Lymphoma; 2018 Mar; 59(3):526-541. PubMed ID: 28604239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of relapsed or refractory acute lymphoblastic leukemia].
    Imai K
    Rinsho Ketsueki; 2017; 58(10):1995-2003. PubMed ID: 28978841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present state.
    Saadeh SS; Litzow MR
    Expert Rev Hematol; 2018 Mar; 11(3):195-207. PubMed ID: 29376437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectives.
    Yilmaz M; Kantarjian H; Ravandi-Kashani F; Short NJ; Jabbour E
    Clin Adv Hematol Oncol; 2018 Mar; 16(3):216-223. PubMed ID: 29742077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant?
    Eapen M
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):317-319. PubMed ID: 29156202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.